Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.64M Buy
+11,000
New +$4.38M 0.02% 510
2026
Q1
– Sell
-350,000
Closed -$115M – 1018
2025
Q4
$115M Buy
+350,000
New +$111M 0.72% 40

Other funds holding AMGN

Marex Group's AMGN Position: Q3 2026 in Review

Marex Group reduced its Amgen (AMGN) stake by 100% in Q3 2026, selling an estimated $78.5M and leaving 831 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1318.

Marex Group first reported a position in AMGN in Q4 2022 and has held it in 11 quarters since. The position peaked at $71.6M in Q2 2026. 3,274 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Marex Group held 831 shares of Amgen worth $350K as of Q3 2026.
  • Marex Group sold 196,840 Amgen shares in Q3 2026, an estimated $78.5M.
  • Amgen made up ﹤0.01% of Marex Group's portfolio in Q3 2026, its #1318 holding.
  • Marex Group first reported a position in Amgen in Q4 2022 and has held it in 11 quarters since.
  • Marex Group's Amgen position peaked at $71.6M in Q2 2026.
  • 3,274 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Marex Group's 13F filing for Q3 2026, filed 16 Nov 2026.